EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers

Lucia Farotti, Federico Paolini Paoletti, Simone Simoni, Lucilla Parnetti

Biomarker Insights · 2020-01 · 15 · 117727192096407

DOI: 10.1177/1177271920964077 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomarker Insights, online erschienen am 12.10.2020. Verfasst von Lucia Farotti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosis of Parkinson’s disease (PD) relies on clinical history and physical examination, but misdiagnosis is common in early stages. Identification of biomarkers for PD may allow for early and more precise diagnosis and provide information about prognosis. Developments in analytical chemistry allow for the detection of a large number of molecules in cerebrospinal fluid (CSF), which are known to be associated with the pathogenesis of PD. Given the pathophysiology of PD, CSF α-synuclein species have the strongest rationale for use, also providing encouraging preliminary results in terms of early diagnosis. In the field of classical Alzheimer’s disease (AD) biomarkers, low CSF Aβ 42 levels have shown a robust prognostic value in terms of development of cognitive impairment. Other CSF biomarkers including lysosomal enzymes, neurofilament light chain, markers of neuroinflammation and oxidative stress, although promising, have not proved to be reliable for diagnostic and prognostic purposes yet. Overall, the implementation of CSF biomarkers may give a substantial contribution to the optimal use of disease-modifying drugs.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s disease biomarkersCerebrospinal fluid biomarkersParkinson’s diseasealpha-synucleininflammationlysosomal enzymesneurofilament light chainoxidative stress

Autor:innen und Institutionen

  • Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy.

Zitieren

APA

Farotti, L., Paolini Paoletti, F., Simoni, S., & Parnetti, L. (2020). Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers. Biomarker Insights, 15, 117727192096407. https://doi.org/10.1177/1177271920964077

Vancouver

Farotti L, Paolini Paoletti F, Simoni S, Parnetti L. Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers. Biomarker Insights. 2020;15:117727192096407. doi:10.1177/1177271920964077

BibTeX
@article{Farotti2020,
  author = {Farotti, Lucia and Paolini Paoletti, Federico and Simoni, Simone and Parnetti, Lucilla},
  title = {Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers},
  journal = {Biomarker Insights},
  year = {2020},
  volume = {15},
  pages = {117727192096407},
  doi = {10.1177/1177271920964077}
}
Kostenlos starten →